The research team projects that the Common Drugs Use in Ophthalmology market size will grow from XXX in 2019 to XXX by 2026, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2026.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 30 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Pfizer
Santen Pharmaceutical
Fresenius
Novartis
Mylan
Bausch Health
Johnson & Johnson
Allergan
Teva Pharmaceutical
Takeda
Chongqing Chemical & Pharmaceutical Holding (Group) Company
APOTEX
Sun Pharmaceutical
Senju Pharmaceutical
GE Medical
Taj Pharmaceuticals
Jamp Pharma
By Type
Anti-inflammatory Drugs
Anti-infective Drugs
Anti-glaucoma Drugs
Anti-allergy Drugs
Anti-VEGF Agents
Others
By Application
Dry Eye
Glaucoma
Infection/Inflammation
Retinal Disorders
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
South Asia
India
Southeast Asia
Indonesia
Thailand
Singapore
Middle East
Turkey
Saudi Arabia
Iran
Africa
Nigeria
South Africa
Oceania
Australia
South America
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Common Drugs Use in Ophthalmology 2015-2020, and development forecast 2021-2026 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2019.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2015-2020 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2021-2026. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Common Drugs Use in Ophthalmology Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).
Market Analysis by Application Type: Based on the Common Drugs Use in Ophthalmology Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Common Drugs Use in Ophthalmology market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 Report Overview
1.1 Study Scope and Definition
1.2 Research Methodology
1.2.1 Methodology/Research Approach
1.2.2 Data Source
1.3 Key Market Segments
1.4 Players Covered: Ranking by Common Drugs Use in Ophthalmology Revenue
1.5 Market Analysis by Type
1.5.1 Global Common Drugs Use in Ophthalmology Market Size Growth Rate by Type: 2020 VS 2026
1.5.2 Anti-inflammatory Drugs
1.5.3 Anti-infective Drugs
1.5.4 Anti-glaucoma Drugs
1.5.5 Anti-allergy Drugs
1.5.6 Anti-VEGF Agents
1.5.7 Others
1.6 Market by Application
1.6.1 Global Common Drugs Use in Ophthalmology Market Share by Application: 2021-2026
1.6.2 Dry Eye
1.6.3 Glaucoma
1.6.4 Infection/Inflammation
1.6.5 Retinal Disorders
1.6.6 Others
1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.7.2 Covid-19 Impact: Commodity Prices Indices
1.7.3 Covid-19 Impact: Global Major Government Policy
1.8 Study Objectives
1.9 Years Considered
2 Global Common Drugs Use in Ophthalmology Market Trends and Growth Strategy
2.1 Market Top Trends
2.2 Market Drivers
2.3 Market Challenges
2.4 Porter's Five Forces Analysis
2.5 Market Growth Strategy
2.6 SWOT Analysis
3 Global Common Drugs Use in Ophthalmology Market Players Profiles
3.1 Pfizer
3.1.1 Pfizer Company Profile
3.1.2 Pfizer Common Drugs Use in Ophthalmology Product Specification
3.1.3 Pfizer Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.2 Santen Pharmaceutical
3.2.1 Santen Pharmaceutical Company Profile
3.2.2 Santen Pharmaceutical Common Drugs Use in Ophthalmology Product Specification
3.2.3 Santen Pharmaceutical Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.3 Fresenius
3.3.1 Fresenius Company Profile
3.3.2 Fresenius Common Drugs Use in Ophthalmology Product Specification
3.3.3 Fresenius Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 Novartis
3.4.1 Novartis Company Profile
3.4.2 Novartis Common Drugs Use in Ophthalmology Product Specification
3.4.3 Novartis Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Mylan
3.5.1 Mylan Company Profile
3.5.2 Mylan Common Drugs Use in Ophthalmology Product Specification
3.5.3 Mylan Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 Bausch Health
3.6.1 Bausch Health Company Profile
3.6.2 Bausch Health Common Drugs Use in Ophthalmology Product Specification
3.6.3 Bausch Health Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Johnson & Johnson
3.7.1 Johnson & Johnson Company Profile
3.7.2 Johnson & Johnson Common Drugs Use in Ophthalmology Product Specification
3.7.3 Johnson & Johnson Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Allergan
3.8.1 Allergan Company Profile
3.8.2 Allergan Common Drugs Use in Ophthalmology Product Specification
3.8.3 Allergan Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Teva Pharmaceutical
3.9.1 Teva Pharmaceutical Company Profile
3.9.2 Teva Pharmaceutical Common Drugs Use in Ophthalmology Product Specification
3.9.3 Teva Pharmaceutical Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Takeda
3.10.1 Takeda Company Profile
3.10.2 Takeda Common Drugs Use in Ophthalmology Product Specification
3.10.3 Takeda Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 Chongqing Chemical & Pharmaceutical Holding (Group) Company
3.11.1 Chongqing Chemical & Pharmaceutical Holding (Group) Company Company Profile
3.11.2 Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Product Specification
3.11.3 Chongqing Chemical & Pharmaceutical Holding (Group) Company Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 APOTEX
3.12.1 APOTEX Company Profile
3.12.2 APOTEX Common Drugs Use in Ophthalmology Product Specification
3.12.3 APOTEX Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.13 Sun Pharmaceutical
3.13.1 Sun Pharmaceutical Company Profile
3.13.2 Sun Pharmaceutical Common Drugs Use in Ophthalmology Product Specification
3.13.3 Sun Pharmaceutical Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.14 Senju Pharmaceutical
3.14.1 Senju Pharmaceutical Company Profile
3.14.2 Senju Pharmaceutical Common Drugs Use in Ophthalmology Product Specification
3.14.3 Senju Pharmaceutical Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.15 GE Medical
3.15.1 GE Medical Company Profile
3.15.2 GE Medical Common Drugs Use in Ophthalmology Product Specification
3.15.3 GE Medical Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.16 Taj Pharmaceuticals
3.16.1 Taj Pharmaceuticals Company Profile
3.16.2 Taj Pharmaceuticals Common Drugs Use in Ophthalmology Product Specification
3.16.3 Taj Pharmaceuticals Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.17 Jamp Pharma
3.17.1 Jamp Pharma Company Profile
3.17.2 Jamp Pharma Common Drugs Use in Ophthalmology Product Specification
3.17.3 Jamp Pharma Common Drugs Use in Ophthalmology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Common Drugs Use in Ophthalmology Market Competition by Market Players
4.1 Global Common Drugs Use in Ophthalmology Production Capacity Market Share by Market Players (2015-2020)
4.2 Global Common Drugs Use in Ophthalmology Revenue Market Share by Market Players (2015-2020)
4.3 Global Common Drugs Use in Ophthalmology Average Price by Market Players (2015-2020)
5 Global Common Drugs Use in Ophthalmology Production by Regions (2015-2020)
5.1 North America
5.1.1 North America Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.1.2 Common Drugs Use in Ophthalmology Key Players in North America (2015-2020)
5.1.3 North America Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.1.4 North America Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.2 East Asia
5.2.1 East Asia Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.2.2 Common Drugs Use in Ophthalmology Key Players in East Asia (2015-2020)
5.2.3 East Asia Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.2.4 East Asia Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.3 Europe
5.3.1 Europe Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.3.2 Common Drugs Use in Ophthalmology Key Players in Europe (2015-2020)
5.3.3 Europe Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.3.4 Europe Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.4 South Asia
5.4.1 South Asia Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.4.2 Common Drugs Use in Ophthalmology Key Players in South Asia (2015-2020)
5.4.3 South Asia Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.4.4 South Asia Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.5 Southeast Asia
5.5.1 Southeast Asia Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.5.2 Common Drugs Use in Ophthalmology Key Players in Southeast Asia (2015-2020)
5.5.3 Southeast Asia Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.5.4 Southeast Asia Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.6 Middle East
5.6.1 Middle East Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.6.2 Common Drugs Use in Ophthalmology Key Players in Middle East (2015-2020)
5.6.3 Middle East Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.6.4 Middle East Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.7 Africa
5.7.1 Africa Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.7.2 Common Drugs Use in Ophthalmology Key Players in Africa (2015-2020)
5.7.3 Africa Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.7.4 Africa Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.8 Oceania
5.8.1 Oceania Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.8.2 Common Drugs Use in Ophthalmology Key Players in Oceania (2015-2020)
5.8.3 Oceania Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.8.4 Oceania Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.9 South America
5.9.1 South America Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.9.2 Common Drugs Use in Ophthalmology Key Players in South America (2015-2020)
5.9.3 South America Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.9.4 South America Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
5.10 Rest of the World
5.10.1 Rest of the World Common Drugs Use in Ophthalmology Market Size (2015-2020)
5.10.2 Common Drugs Use in Ophthalmology Key Players in Rest of the World (2015-2020)
5.10.3 Rest of the World Common Drugs Use in Ophthalmology Market Size by Type (2015-2020)
5.10.4 Rest of the World Common Drugs Use in Ophthalmology Market Size by Application (2015-2020)
6 Global Common Drugs Use in Ophthalmology Consumption by Region (2015-2020)
6.1 North America
6.1.1 North America Common Drugs Use in Ophthalmology Consumption by Countries
6.1.2 United States
6.1.3 Canada
6.1.4 Mexico
6.2 East Asia
6.2.1 East Asia Common Drugs Use in Ophthalmology Consumption by Countries
6.2.2 China
6.2.3 Japan
6.2.4 South Korea
6.3 Europe
6.3.1 Europe Common Drugs Use in Ophthalmology Consumption by Countries
6.3.2 Germany
6.3.3 United Kingdom
6.3.4 France
6.3.5 Italy
6.3.6 Russia
6.3.7 Spain
6.3.8 Netherlands
6.3.9 Switzerland
6.3.10 Poland
6.4 South Asia
6.4.1 South Asia Common Drugs Use in Ophthalmology Consumption by Countries
6.4.2 India
6.5 Southeast Asia
6.5.1 Southeast Asia Common Drugs Use in Ophthalmology Consumption by Countries
6.5.2 Indonesia
6.5.3 Thailand
6.5.4 Singapore
6.5.5 Malaysia
6.5.6 Philippines
6.6 Middle East
6.6.1 Middle East Common Drugs Use in Ophthalmology Consumption by Countries
6.6.2 Turkey
6.6.3 Saudi Arabia
6.6.4 Iran
6.6.5 United Arab Emirates
6.7 Africa
6.7.1 Africa Common Drugs Use in Ophthalmology Consumption by Countries
6.7.2 Nigeria
6.7.3 South Africa
6.8 Oceania
6.8.1 Oceania Common Drugs Use in Ophthalmology Consumption by Countries
6.8.2 Australia
6.9 South America
6.9.1 South America Common Drugs Use in Ophthalmology Consumption by Countries
6.9.2 Brazil
6.9.3 Argentina
6.10 Rest of the World
6.10.1 Rest of the World Common Drugs Use in Ophthalmology Consumption by Countries
7 Global Common Drugs Use in Ophthalmology Production Forecast by Regions (2021-2026)
7.1 Global Forecasted Production of Common Drugs Use in Ophthalmology (2021-2026)
7.2 Global Forecasted Revenue of Common Drugs Use in Ophthalmology (2021-2026)
7.3 Global Forecasted Price of Common Drugs Use in Ophthalmology (2021-2026)
7.4 Global Forecasted Production of Common Drugs Use in Ophthalmology by Region (2021-2026)
7.4.1 North America Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.2 East Asia Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.3 Europe Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.4 South Asia Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.5 Southeast Asia Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.6 Middle East Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.7 Africa Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.8 Oceania Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.9 South America Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.4.10 Rest of the World Common Drugs Use in Ophthalmology Production, Revenue Forecast (2021-2026)
7.5 Forecast by Type and by Application (2021-2026)
7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
7.5.2 Global Forecasted Consumption of Common Drugs Use in Ophthalmology by Application (2021-2026)
8 Global Common Drugs Use in Ophthalmology Consumption Forecast by Regions (2021-2026)
8.1 North America Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.2 East Asia Market Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.3 Europe Market Forecasted Consumption of Common Drugs Use in Ophthalmology by Countriy
8.4 South Asia Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.5 Southeast Asia Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.6 Middle East Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.7 Africa Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.8 Oceania Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.9 South America Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
8.10 Rest of the world Forecasted Consumption of Common Drugs Use in Ophthalmology by Country
9 Global Common Drugs Use in Ophthalmology Sales by Type (2015-2026)
9.1 Global Common Drugs Use in Ophthalmology Historic Market Size by Type (2015-2020)
9.2 Global Common Drugs Use in Ophthalmology Forecasted Market Size by Type (2021-2026)
10 Global Common Drugs Use in Ophthalmology Consumption by Application (2015-2026)
10.1 Global Common Drugs Use in Ophthalmology Historic Market Size by Application (2015-2020)
10.2 Global Common Drugs Use in Ophthalmology Forecasted Market Size by Application (2021-2026)
11 Global Common Drugs Use in Ophthalmology Manufacturing Cost Analysis
11.1 Common Drugs Use in Ophthalmology Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.3 Manufacturing Process Analysis of Common Drugs Use in Ophthalmology
12 Global Common Drugs Use in Ophthalmology Marketing Channel, Distributors, Customers and Supply Chain
12.1 Marketing Channel
12.2 Common Drugs Use in Ophthalmology Distributors List
12.3 Common Drugs Use in Ophthalmology Customers
12.4 Common Drugs Use in Ophthalmology Supply Chain Analysis
13 Analyst's Viewpoints/Conclusions
14 Disclaimer
The Ophthalmology Practice Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...
Overview of the Global Drug Rehabilitation Drugs Market :
The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...